NEW YORK (AP) — NEW YORK (AP) — Neurogene Inc. (NGNE) on Thursday reported a loss of $21 million in its third quarter.
On a per-share basis, the New York-based company said it had a loss of 99 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.26 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NGNE at https://www.zacks.com/ap/NGNE
/Semiconductor%20Chip%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)